1h Free Analyst Time
The publisher has been monitoring the natamycin market and it is poised to grow by $12.35 mn during 2022-2026 progressing at a CAGR of 3.34% during the forecast period. The report on the natamycin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for dairy and meat products, increased use in antifungal pharmaceutical products, and the long-lasting antifungal effect of natamycin.
The natamycin market analysis includes application segment and geographic landscape.
The natamycin market is segmented as below:
By Application
- food and beverages
- pharmaceuticals
- personal care
- others
By Geographical Landscape
- APAC
- North America
- Europe
- South America
- The Middle East and Africa
This study identifies the rising consumption of ready-to-eat food products as one of the prime reasons driving the natamycin market growth during the next few years. Also, an increase in the incidence of fungal infections, and natural preferred additives in the food industry will lead to sizable demand in the market.
The report on the natamycin market covers the following areas:
- Natamycin market sizing
- Natamycin market forecast
- Natamycin market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading natamycin market vendors that include Beijing Oriental Rada Biotech Co. Ltd., ChihonBio Co. Ltd., Handary SA, Indukern SA, Koninklijke DSM NV, Meihua Holdings Group Co. Ltd., Novartis Pharmaceuticals Corp., Siveele BV, Fujian life come biochemistry Ltd., Zhejiang Silver Elephant Bio-Engineering Co. Ltd., and DuPont de Nemours Inc. Also, the natamycin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2. Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3. Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4. Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5. Market Segmentation by Application
5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Food and beverages - Market size and forecast 2021-2026
Exhibit 28: Chart on Food and beverages - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Food and beverages - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Food and beverages - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Food and beverages - Year-over-year growth 2021-2026 (%)
5.4 Pharmaceuticals - Market size and forecast 2021-2026
Exhibit 32: Chart on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
5.5 Personal care - Market size and forecast 2021-2026
Exhibit 36: Chart on Personal care - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Personal care - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Personal care - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Personal care - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Application
Exhibit 44: Market opportunity by Application ($ million)
6. Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 APAC - Market size and forecast 2021-2026
Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
7.4 North America - Market size and forecast 2021-2026
Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.5 Europe - Market size and forecast 2021-2026
Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.6 South America - Market size and forecast 2021-2026
Exhibit 62: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on South America - Year-over-year growth 2021-2026 (%)
7.7 Middle East and Africa - Market size and forecast 2021-2026
Exhibit 66: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
7.8 US - Market size and forecast 2021-2026
Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Japan - Market size and forecast 2021-2026
Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.11 Germany - Market size and forecast 2021-2026
Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.12 Canada - Market size and forecast 2021-2026
Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 90: Market opportunity By Geographical Landscape ($ million)
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9. Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 93: Overview on factors of disruption
9.4 Industry risks
Exhibit 94: Impact of key risks on business
10. Vendor Analysis
10.1 Vendors covered
Exhibit 95: Vendors covered
10.2 Market positioning of vendors
Exhibit 96: Matrix on vendor position and classification
10.3 Beijing Oriental Rada Biotech Co. Ltd.
Exhibit 97: Beijing Oriental Rada Biotech Co. Ltd. - Overview
Exhibit 98: Beijing Oriental Rada Biotech Co. Ltd. - Business segments
Exhibit 99: Beijing Oriental Rada Biotech Co. Ltd. - Key offerings
Exhibit 100: Beijing Oriental Rada Biotech Co. Ltd. - Segment focus
10.4 ChihonBio Co. Ltd.
Exhibit 101: ChihonBio Co. Ltd. - Overview
Exhibit 102: ChihonBio Co. Ltd. - Business segments
Exhibit 103: ChihonBio Co. Ltd. - Key offerings
Exhibit 104: ChihonBio Co. Ltd. - Segment focus
10.5 DuPont de Nemours Inc.
Exhibit 105: DuPont de Nemours Inc. - Overview
Exhibit 106: DuPont de Nemours Inc. - Business segments
Exhibit 107: DuPont de Nemours Inc. - Key offerings
Exhibit 108: DuPont de Nemours Inc. - Segment focus
10.6 Fujian lifecome biochemistry Ltd.
Exhibit 109: Fujian lifecome biochemistry Ltd. - Overview
Exhibit 110: Fujian lifecome biochemistry Ltd. - Business segments
Exhibit 111: Fujian lifecome biochemistry Ltd. - Key offerings
Exhibit 112: Fujian lifecome biochemistry Ltd. - Segment focus
10.7 Handary SA
Exhibit 113: Handary SA - Overview
Exhibit 114: Handary SA - Key offerings
10.8 Indukern SA
Exhibit 115: Indukern SA - Overview
Exhibit 116: Indukern SA - Business segments
Exhibit 117: Indukern SA - Key offerings
Exhibit 118: Indukern SA - Segment focus
10.9 Koninklijke DSM NV
Exhibit 119: Koninklijke DSM NV - Overview
Exhibit 120: Koninklijke DSM NV - Business segments
Exhibit 121: Koninklijke DSM NV - Key news
Exhibit 122: Koninklijke DSM NV - Key offerings
Exhibit 123: Koninklijke DSM NV - Segment focus
10.10 Novartis Pharmaceuticals Corp.
Exhibit 124: Novartis Pharmaceuticals Corp. - Overview
Exhibit 125: Novartis Pharmaceuticals Corp. - Business segments
Exhibit 126: Novartis Pharmaceuticals Corp. - Key offerings
Exhibit 127: Novartis Pharmaceuticals Corp. - Segment focus
10.11 Siveele BV
Exhibit 128: Siveele BV - Overview
Exhibit 129: Siveele BV - Business segments
Exhibit 130: Siveele BV - Key offerings
Exhibit 131: Siveele BV - Segment focus
10.12 Zhejiang Silver Elephant Bio Engineering Co. Ltd.
Exhibit 132: Zhejiang Silver Elephant Bio Engineering Co. Ltd. - Overview
Exhibit 133: Zhejiang Silver Elephant Bio Engineering Co. Ltd. - Product / Service
Exhibit 134: Zhejiang Silver Elephant Bio Engineering Co. Ltd. - Key offerings
11. Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 135: Inclusions checklist
Exhibit 136: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 137: Currency conversion rates for US$
11.4 Research methodology
Exhibit 138: Research methodology
Exhibit 139: Validation techniques employed for market sizing
Exhibit 140: Information sources
11.5 List of abbreviations
Exhibit 141: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Application - Market share 2021-2026 (%)
Exhibits 25: Data Table on Application - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Application
Exhibits 27: Data Table on Comparison by Application
Exhibits 28: Chart on Food and beverages - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Food and beverages - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Food and beverages - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Food and beverages - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Personal care - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Personal care - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Personal care - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Personal care - Year-over-year growth 2021-2026 (%)
Exhibits 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 44: Market opportunity by Application ($ million)
Exhibits 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 48: Chart on Geographic comparison
Exhibits 49: Data Table on Geographic comparison
Exhibits 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on South America - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 86: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 87: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 90: Market opportunity By Geographical Landscape ($ million)
Exhibits 91: Impact of drivers and challenges in 2021 and 2026
Exhibits 92: Overview on Criticality of inputs and Factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Vendors covered
Exhibits 96: Matrix on vendor position and classification
Exhibits 97: Beijing Oriental Rada Biotech Co. Ltd. - Overview
Exhibits 98: Beijing Oriental Rada Biotech Co. Ltd. - Business segments
Exhibits 99: Beijing Oriental Rada Biotech Co. Ltd. - Key offerings
Exhibits 100: Beijing Oriental Rada Biotech Co. Ltd. - Segment focus
Exhibits 101: ChihonBio Co. Ltd. - Overview
Exhibits 102: ChihonBio Co. Ltd. - Business segments
Exhibits 103: ChihonBio Co. Ltd. - Key offerings
Exhibits 104: ChihonBio Co. Ltd. - Segment focus
Exhibits 105: DuPont de Nemours Inc. - Overview
Exhibits 106: DuPont de Nemours Inc. - Business segments
Exhibits 107: DuPont de Nemours Inc. - Key offerings
Exhibits 108: DuPont de Nemours Inc. - Segment focus
Exhibits 109: Fujian lifecome biochemistry Ltd. - Overview
Exhibits 110: Fujian lifecome biochemistry Ltd. - Business segments
Exhibits 111: Fujian lifecome biochemistry Ltd. - Key offerings
Exhibits 112: Fujian lifecome biochemistry Ltd. - Segment focus
Exhibits 113: Handary SA - Overview
Exhibits 114: Handary SA - Key offerings
Exhibits 115: Indukern SA - Overview
Exhibits 116: Indukern SA - Business segments
Exhibits 117: Indukern SA - Key offerings
Exhibits 118: Indukern SA - Segment focus
Exhibits 119: Koninklijke DSM NV - Overview
Exhibits 120: Koninklijke DSM NV - Business segments
Exhibits 121: Koninklijke DSM NV - Key news
Exhibits 122: Koninklijke DSM NV - Key offerings
Exhibits 123: Koninklijke DSM NV - Segment focus
Exhibits 124: Novartis Pharmaceuticals Corp. - Overview
Exhibits 125: Novartis Pharmaceuticals Corp. - Business segments
Exhibits 126: Novartis Pharmaceuticals Corp. - Key offerings
Exhibits 127: Novartis Pharmaceuticals Corp. - Segment focus
Exhibits 128: Siveele BV - Overview
Exhibits 129: Siveele BV - Business segments
Exhibits 130: Siveele BV - Key offerings
Exhibits 131: Siveele BV - Segment focus
Exhibits 132: Zhejiang Silver Elephant Bio Engineering Co. Ltd. - Overview
Exhibits 133: Zhejiang Silver Elephant Bio Engineering Co. Ltd. - Product / Service
Exhibits 134: Zhejiang Silver Elephant Bio Engineering Co. Ltd. - Key offerings
Exhibits 135: Inclusions checklist
Exhibits 136: Exclusions checklist
Exhibits 137: Currency conversion rates for US$
Exhibits 138: Research methodology
Exhibits 139: Validation techniques employed for market sizing
Exhibits 140: Information sources
Exhibits 141: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global natamycin market: Beijing Oriental Rada Biotech Co. Ltd., ChihonBio Co. Ltd., Handary SA, Indukern SA, Koninklijke DSM NV, Meihua Holdings Group Co. Ltd., Novartis Pharmaceuticals Corp., Siveele BV, Fujian life come biochemistry Ltd., Zhejiang Silver Elephant Bio-Engineering Co. Ltd., and DuPont de Nemours Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rising consumption of ready-to-eat food products.`
According to the report, one of the major drivers of this market is the increased demand for dairy and meat products.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Beijing Oriental Rada Biotech Co. Ltd.
- ChihonBio Co. Ltd.
- Handary SA
- Indukern SA
- Koninklijke DSM NV
- Meihua Holdings Group Co. Ltd.
- Novartis Pharmaceuticals Corp.
- Siveele BV
- Fujian lifecome biochemistry Ltd.
- Zhejiang Silver Elephant Bio Engineering Co. Ltd.
- DuPont de Nemours Inc.
